Atomik Labz vs Simple Peptide Labs: The Coverage Reversal

The atomik labz vs simple peptide labs comparison is the clearest example in this hub of why raw catalogue counts mislead. One side lists more entries; the other documents a larger share of what it lists. Depending on which number you use, the ranking reverses. Both numbers are real, and a comparison that reports only one is choosing a conclusion before doing the work.

This record reports both, then applies the same four criteria used across the hub: documentation depth, breadth, pricing transparency and dispute evidence.

Raw count versus documented count

The raw count is the number of distinct compounds listed. The documented count is the number with a lot-specific certificate that includes a method, a result and a verifiable report number. The second number is smaller for both vendors, and the ratio between them is the useful metric: documented coverage.

Coverage can be reported per compound family. Older, well-characterised compounds tend to have better documentation because reference standards and methods are easier to obtain. Newer entries are often listed before they are documented, which inflates the raw count without adding evidence. The record marks that pattern where it appears.

Where the ranking reverses

When breadth is weighted by coverage, the vendor with fewer entries can come out ahead. That result is not a quality verdict; it means the catalogue's claims are more frequently supported by documents. A reader who values verifiability over selection will weight it differently from a reader who needs a specific compound that only one side stocks.

The record states the reversal explicitly because it is the most useful finding in the comparison and the one a star-rating page would miss. It also states the limitation: coverage is measured from public archives, and a vendor may hold documents it does not publish. The public record is the only record a desk review can use.

Price and disputes

Pricing transparency is broadly similar, with both sides mixing pack-level and kit-level prices. Normalisation is possible for some entries and not others, so the record reports a range rather than a point estimate. Dispute evidence is thin for both, with fulfilment accounts more common than documentation accounts.

The closing note names the artefacts that would settle the comparison: a published coverage table, a failure policy and dated resolution records. Until those exist, the honest summary is that one side lists more and the other documents more, and the choice depends on which property the reader needs.

Standing method for the comparison ledger

Four criteria are fixed before any vendor is examined: documentation depth, catalogue breadth, pricing transparency and dispute evidence. Each is assessed from public artefacts, and each is reported separately. No criterion is converted into a score, because the criteria do not share a unit and any weighting would be a preference presented as a measurement.

Where evidence is missing, the record says 'not assessable' rather than assigning a neutral mark. A neutral mark rewards absence, since a vendor with no documents and a vendor with adequate documents would end up equal. The ledger is designed to make that error impossible, even at the cost of feeling inconclusive.

Coverage is not a quality score

A high documented coverage ratio means a larger share of the catalogue has a verifiable report. It does not mean the reports are good, the material is pure or the batches are current. Coverage measures documentation practice, which is one dimension of a vendor record and not a summary of it.

The record states this explicitly because coverage is easy to turn into a pseudo-score. A reader who reads it as a quality metric will over-weight the vendor with better paperwork, which may be the correct choice for a documentation-sensitive buyer and the wrong one for a buyer who needs a compound only the other side stocks.